# Trending Content OS — Daily Run
**Run date:** 2026-09-23 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

| Check | Status |
|---|---|
| Config files (7/7) | ✅ all loaded |
| `site_niche` / `target_audience` | ✅ set |
| `site_url` | ⚠️ not set — self-check skipped, competitor-list fallback used |
| SerpAPI connection | ✅ active (injected pre-fetch) |
| Google Trends | ✅ available — `search_velocity_source: google_trends`, `google_trends_tool: serpapi_prefetch` |
| Google News Radar | ✅ 144 unique headlines across 12 queries |
| `data/deferred_topics.yaml` | No entries past `recheck_on` today |
| Recurring themes (run_history) | Hand soap recall, egg recall, AI-in-medicine, Ebola outbreak all appearing 2+ consecutive runs — flagged for staleness watch |

`next_action: run_signal_listener` → executed.

---

## 2. Google News Radar Coverage Summary

**Retained (new signal or material update):**
- **Measles / CDC data controversy** — real-time Trends breakout + [The Guardian](https://www.theguardian.com/us-news/2026/sep/20/trump-order-nih-health-research-funding-board)-adjacent public-health accountability story. *(Note: linked article above is the NIH board story; measles source is [The Guardian — CDC measles deaths](https://theguardian.com) per Trending Now citation.)*
- **GLP-1 drugs used without medical reason** — [NYT Well](https://www.nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html)
- **PATHFINDER 2 multi-cancer early detection test** — [Nature](https://www.nature.com/articles/s41591-026-04618-w)
- **Nicotine "wellness" rebranding** — [Washington Post](https://www.washingtonpost.com/health/2026/09/20/im-pulmonologist-heres-why-new-wellness-claims-about-nicotine-worry-me/) + [The Conversation](https://theconversation.com/how-the-pro-nicotine-wellness-movement-rebranded-an-addictive-drug-290129)
- **Ebola vaccination campaign begins (DRC)** — [PBS](https://www.pbs.org/newshour/world/congo-begins-ebola-vaccinations-for-health-workers-in-the-epicenter-of-the-outbreak) — **update** to 09/17 outbreak coverage

**Rejected — existing/no new development:**
- FDA hand soap recall cluster (multiple outlets) — already covered through Class II reclassification 09/19; no escalation since.
- Egg/Salmonella recall (Class I upgrade) — already covered 09/20; [ABC News](https://abcnews.com/GMA/Food/19-million-eggs-voluntarily-recalled-potential-salmonella-contamination/story?id=135028861) repeats same fact.
- Stanford "two brains" study — covered 09/20, no new angle in today's radar.
- Alzheimer's funding-cuts story ([The Guardian](https://www.theguardian.com/us-news/2026/sep/17/trump-cuts-alzheimers-disease-study)) — covered 09/18, no update.

**Rejected — off-category / brand safety / weak sourcing:**
- Health-system business & insurance-economics cluster (KFF rural transformation, Harold Hamm gift, insurance premium 2027, Yale spending study, WaPo insurance-skipping piece) — business/policy edge, weak audience fit.
- Trump NIH funding board / "woke" veto ([The Guardian](https://www.theguardian.com/us-news/2026/sep/20/trump-order-nih-health-research-funding-board)) — **rejected: pure political healthcare policy**, excluded category.
- Local/PR wellness cluster (Haines wellness grant, Coast Guard EAP, Aurora wellness hub, UWM SHAW visit, Black Men's Wellness Day, gorilla wellness checkup, Harkin Institute hire, wellness real-estate boom, CNBC consumer-spending piece) — local/off-category, no national health angle.
- Clinical-trial trade/process cluster (ClinicalTrials.gov checkbox, benchmarking operating models, Well Health platform launch, ResearchPass app, IMPACT Collaboratory scholars program, UNC Ireland trip, Padres/doctor human-interest) — B2B/industry, not audience-facing.
- Blood pressure medication recall (Facebook/Boston25 post) — **rejected at Skill 02b**, see below.
- So Delicious ice cream recall ([NY Post](https://nypost.com/2026/09/17/lifestyle/so-delicious-ice-cream-recalled-nationwide-over-stones-found-in-pints-fda/)) — stale (6 days old, exceeds recall freshness ceiling, no escalation).
- Male-focused medical research bias in AI (Ms. Magazine) — single weak source, opinion-adjacent.
- "Health benefits of reading" (Time) — saturated evergreen topic, single thin source.
- Down syndrome immune study, stroke recovery study, hospice research, pregnancy-cravings study — niche/single-source, held at monitor tier, not briefed today due to thin sourcing.

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-23T00:00:00Z"
  run_completed_at: "2026-09-23T00:20:00Z"
  total_signals_reviewed: 153
  total_signals_retained: 5
  total_rejected: 148
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 68
    brand_safety: 1
    duplicate: 12
    weak_signal: 58
    unverified_claim: 1
    other: 8
  highest_priority_topic: "GLP-1 drugs used without medical reason (NYT study)"
  strongest_signal_source: "Nature — PATHFINDER 2 multi-cancer detection study"
  tools_unavailable: []
  notes: >
    Google News Radar's dominant clusters were local/PR wellness events and
    health-industry business news — both largely off-category for this audience.
    Recall clusters (hand soap, eggs) are recurring across 3+ runs with no new
    escalation and were suppressed as existing. Measles/CDC story is single-sourced
    on the specific claim but corroborated by real-time Google Trends breakout;
    flagged for confirmation before publish.
```

---

## 4. Skill 02b — Health Claim Verification Gate: Routing Summary

| Topic | Risk Type | Gate Result | Primary Source | Notes |
|---|---|---|---|---|
| GLP-1 drugs without medical reason | drug_or_treatment_claim (usage pattern) | **Pass** | trusted_secondary (NYT Well names study) | Confidence not capped |
| PATHFINDER 2 cancer detection test | medical_study / clinical_trial | **Pass** | journal/DOI (Nature primary) | Strong primary source |
| Blood pressure medication recall (FB post) | recall | **Reject** | none | Single non-authoritative source, drug unnamed, no FDA.gov notice, breaking-recall exception not met (needs 3+ credible sources) — `rejection_reason: unverifiable_health_claim` |
| Nicotine "wellness" rebranding | not_applicable | N/A | — | Cultural/media-trend piece built on already-published expert skepticism (WaPo pulmonologist), not a new drug/safety assertion — gate not triggered |
| Hand soap / egg recalls | recall | Not re-run | — | Already resolved `existing`, suppressed before reaching 02b |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Trend | Opp | Discover | Urgency | Confidence | Status |
|---|---|---|---|---|---|---|---|
| **P1** | Measles outbreak — CDC excludes PA deaths | 65 | 80 | 4 | now | medium | new |
| **P1** | GLP-1 drugs used without medical reason | 72 | 80 | 4 | today | medium | new |
| **P2** | PATHFINDER 2 multi-cancer detection test | 63 | 80 | 5 | today | medium | new |
| **P2** | Ebola vaccination campaign begins (DRC) | 51 | 73 | 3 | today | medium | update |
| **P2** | Nicotine "wellness" rebranding — skepticism piece | 57 | 71 | 3 | this_week | medium | new |

---

## 6. Editorial Briefs

### P1 — Measles: Why the CDC Isn't Counting Pennsylvania's Measles Deaths
```yaml
topic: "CDC excludes Pennsylvania measles deaths from official count amid accelerating outbreak"
primary_entity: "CDC"
signal_type: breaking_news
allowed_category: "public health and epidemiology"
trend_strength_score: 65
opportunity_score: 80
discover_score: 4
urgency: now
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Explain the CDC's death-count methodology dispute and what it means for how bad the outbreak actually is — accountability/explainer angle, not alarmism."
why_now: "Measles is a real-time Google Trends breakout term nationally, directly tied to this developing CDC accountability story as the outbreak accelerates."
primary_headline: "Why Pennsylvania's Measles Deaths Aren't in the CDC's Official Count"
next_steps: "Corroborate the exclusion claim directly against CDC.gov surveillance data before publishing; pair with current national case-count context."
notes: "Single-source (Guardian) on the specific CDC-methodology claim; broader outbreak trend is separately supported by real-time search breakout."
integrity_flags:
  - "⚠️ Integrity note: verify CDC count-exclusion claim against primary CDC.gov surveillance page before publication — only one outlet currently reports this detail."
sources:
  - { publisher: "The Guardian", url: "https://www.theguardian.com", tier: 2, used_for: "Primary reporting on CDC data exclusion" }
estimated_word_count: "900-1100"
```

### P1 — GLP-1 Drugs Used Without a Medical Reason
```yaml
topic: "Many Americans use GLP-1 drugs without a documented medical reason, study shows"
primary_entity: "GLP-1 receptor agonists (Ozempic/Wegovy class)"
signal_type: study_or_research
allowed_category: "chronic disease management"
trend_strength_score: 72
opportunity_score: 80
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Evaluative: what 'no documented medical reason' actually means clinically, and what it signals about off-label/aesthetic GLP-1 demand."
why_now: "NYT Well study coverage lands alongside sustained public interest in weight-loss drugs; extends existing GLP-1/Ozempic-access content cluster with new usage-pattern data."
primary_headline: "Why So Many Americans Are Taking Ozempic-Class Drugs Without a Clear Medical Reason"
next_steps: "Trace the underlying study (named in NYT Well piece) to its journal source; add RDN or endocrinologist commentary on appropriate-use criteria."
notes: "Passed 02b as trusted-secondary (NYT names study); confirm primary journal citation before drafting."
integrity_flags:
  - "⚠️ Integrity note: distinguish 'without documented medical reason' from 'unsafe use' — study measures documentation gaps, not necessarily misuse."
sources:
  - { publisher: "The New York Times (Well)", url: "https://www.nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html", tier: 1, used_for: "Primary study coverage" }
estimated_word_count: "1000-1200"
```

### P2 — PATHFINDER 2 Multi-Cancer Early Detection Test
```yaml
topic: "PATHFINDER 2 study evaluates performance and safety of a multi-cancer early detection blood test"
primary_entity: "PATHFINDER 2 study (multi-cancer early detection test)"
signal_type: study_or_research
allowed_category: "medical research and clinical trials"
trend_strength_score: 63
opportunity_score: 80
discover_score: 5
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Explainer: how accurate is this blood test really, and who should (and shouldn't) get one — cut through screening-test hype with the actual sensitivity/specificity data."
why_now: "Freshly published Nature study with a specific, traceable DOI and no dedicated consumer-facing coverage yet — clear SERP gap."
primary_headline: "A New Blood Test Screens for Multiple Cancers at Once. Here's What the Data Actually Shows"
next_steps: "Pull sensitivity/specificity/false-positive figures directly from the Nature paper; seek an oncologist or screening-guidelines expert for context on when this test is/isn't appropriate."
notes: "Highest Discover score in this run — named study, DOI, durable consumer question, thin existing coverage."
integrity_flags:
  - "⚠️ Integrity note: report true/false-positive rates explicitly — avoid framing this as a definitive cancer diagnostic rather than a screening aid."
sources:
  - { publisher: "Nature", url: "https://www.nature.com/articles/s41591-026-04618-w", tier: 1, used_for: "Primary study data" }
estimated_word_count: "1000-1200"
```

### P2 — Ebola: Vaccination Campaign Begins in DRC Epicenter (Update)
```yaml
topic: "Congo begins Ebola vaccinations for health workers in outbreak epicenter"
primary_entity: "Ebola outbreak (DRC/Uganda)"
signal_type: breaking_news
allowed_category: "infectious disease"
trend_strength_score: 51
opportunity_score: 73
discover_score: 3
urgency: today
confidence: medium
content_status: update
source_count: 1
recommended_angle: "Update-driven: first proactive containment measure since outbreak was reported — explain the vaccine being used and what it signals about outbreak trajectory."
why_now: "Material new development since 09/17 coverage: health-worker vaccination campaign has now begun in the epicenter, the first containment escalation reported."
primary_headline: "Ebola Vaccinations Begin for Health Workers as DRC Outbreak Continues to Spread"
next_steps: "Confirm vaccine identity/manufacturer via WHO; update case-count figures from WHO Disease Outbreak News feed."
notes: "Single new source (PBS) for this specific development; cumulative outbreak story has multi-source support from prior coverage."
integrity_flags: []
sources:
  - { publisher: "PBS NewsHour", url: "https://www.pbs.org/newshour/world/congo-begins-ebola-vaccinations-for-health-workers-in-the-epicenter-of-the-outbreak", tier: 2, used_for: "Vaccination campaign update" }
estimated_word_count: "600-800"
```

### P2 — Nicotine "Wellness" Rebranding: Does It Actually Hold Up?
```yaml
topic: "The pro-nicotine 'wellness' movement rebrands an addictive drug"
primary_entity: "Nicotine wellness marketing trend"
signal_type: cultural_moment
allowed_category: "public health and epidemiology"
trend_strength_score: 57
opportunity_score: 71
discover_score: 3
urgency: this_week
confidence: medium
content_status: new
source_count: 2
recommended_angle: "Skepticism-driven: 'Does nicotine-as-wellness actually check out?' — synthesize WaPo pulmonologist pushback + Conversation analysis into a single debunking explainer."
why_now: "Two independent credible outlets (WaPo, The Conversation) converged on the same emerging narrative within days of each other — early enough that no aggregated take exists yet."
primary_headline: "Nicotine Is Being Marketed as 'Wellness.' Doctors Say That's a Problem."
next_steps: "Cite the WaPo pulmonologist's column directly; add CDC/FDA nicotine-health data for factual grounding; avoid amplifying unproven wellness claims even while debunking them."
notes: "02b not triggered — this is media/marketing-trend analysis built on already-published expert skepticism, not a new safety or dosage assertion."
integrity_flags:
  - "⚠️ Integrity note: frame explicitly as a critique of marketing claims, not neutral coverage of nicotine as a wellness product — avoid inadvertent normalization."
sources:
  - { publisher: "The Washington Post", url: "https://www.washingtonpost.com/health/2026/09/20/im-pulmonologist-heres-why-new-wellness-claims-about-nicotine-worry-me/", tier: 1, used_for: "Expert (pulmonologist) pushback" }
  - { publisher: "The Conversation", url: "https://theconversation.com/how-the-pro-nicotine-wellness-movement-rebranded-an-addictive-drug-290129", tier: 2, used_for: "Trend/marketing analysis" }
estimated_word_count: "700-900"
```

---

## 7. Rejected Topics Log (Selected)

| Topic | Reason |
|---|---|
| FDA hand soap recall | `existing` — no escalation since 09/19 Class II confirmation |
| Egg/Salmonella recall Class I | `existing` — no development since 09/20 |
| Stanford "two brains" study | `existing` — no new angle |
| Alzheimer's funding-cuts story | `existing` — no update |
| Blood pressure medication recall (FB post) | **Rejected at 02b** — unverifiable, single non-authoritative source, drug unnamed |
| So Delicious ice cream recall | Stale — 6 days old, exceeds recall freshness ceiling, no escalation |
| Trump NIH funding board / "woke" veto | Brand safety — pure political healthcare policy, excluded category |
| Insurance premium/spending cluster (KFF, Healthinsurance.org, Yale, WaPo) | Off-category — business/policy edge, weak audience fit |
| Local/PR wellness cluster (10+ items) | Off-category — local/promotional, no national health angle |
| Clinical-trial trade/process cluster (7 items) | Off-category — B2B/industry journalism |
| Male-focused research bias in AI (Ms. Magazine) | Weak signal — single low-tier source, opinion-adjacent |
| "Health benefits of reading" (Time) | Weak signal — saturated evergreen topic, single source |
| Down syndrome immune study, stroke recovery, hospice research, pregnancy-cravings study | Weak signal — niche, single-source, held at monitor tier |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ **Measles/CDC story**: single-source claim on CDC data exclusion — verify against CDC.gov before publishing.
- ⚠️ **GLP-1 study**: distinguish "no documented medical reason" from "unsafe/misuse" — don't overstate.
- ⚠️ **PATHFINDER 2**: report true/false-positive rates explicitly; frame as screening aid, not diagnostic.
- ⚠️ **Nicotine wellness piece**: frame as critique of marketing claims, not neutral wellness coverage.

---

## 9. Run Notes

- `site_url` not configured; competitor-list fallback used for SERP-gap/duplicate context per `configs/competitor_list.yaml`.
- Recurring themes flagged for staleness watch: **FDA recall cluster** (hand soap + eggs, 3+ consecutive runs, no new development — suppressed today) and **AI-in-medicine** (recurring since 09/16, today's WHO AI-ethics item was too thin/adjacent to re-brief).
- Google News Radar's two largest clusters (local/PR wellness, health-industry business news) were both judged off-category — worth reviewing `GOOGLE_NEWS_QUERIES` if this pattern persists, per the rejection-trend note in engineering docs (off-category has historically been the largest rejection bucket).
- Run archived to `data/run_history.yaml`; dashboard written to `outputs/daily_newsroom_dashboard/2026-09-23.html`.